Antitumor Activity of the Polo-Like Kinase Inhibitor, TAK-960, Against Preclinical Models of Colorectal Cancer
BMC Cancer - United Kingdom
doi 10.1186/s12885-018-4036-z
Full Text
Open PDFAbstract
Available in full text
Date
February 5, 2018
Authors
Publisher
Springer Science and Business Media LLC